secwatch.observer — SEC 8-K summary
======================================

Issuer:     EQRx, Inc. (—)
CIK:        0001843762
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001193125-23-274145
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EQRx completes merger with Revolution Medicines; each share converts into 0.1112 RVMD shares
--------------------------------------------------------------------------------

- Shareholders receive 0.1112 Revolution Medicines shares per EQRx share; fractional shares paid cash at $21.18.
- EQRx stock and warrants delisted from Nasdaq; Forms 25 and 15 to deregister and suspend Exchange Act reporting.
- Entire board and named executive officers resign; Revolution Medicines appoints new managers for EQRx, LLC.
- Special meeting on Nov 8, 2023: 377,726,585 votes for merger; 29,217 against; 315,652 abstentions; quorum 70.32%.
- In-the-money EQRx options and RSUs converted into Revolution Medicines shares; out-of-the-money options terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1843762/000119312523274145/0001193125-23-274145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1843762/000119312523274145/d569619d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-274145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer